2010
DOI: 10.1016/j.antiviral.2010.02.312
|View full text |Cite
|
Sign up to set email alerts
|

A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-α-2b and nucleoside analogues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
67
1
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(70 citation statements)
references
References 39 publications
1
67
1
1
Order By: Relevance
“…Similarly to hepaciviruses, p7 plays an essential role in the life cycle of pestiviruses and contributes to their pathogenicity (Gladue et al, 2012;Griffin et al, 2004;Luscombe et al, 2010). It has been argued that the pestivirus p7 constitutes a general model for the HCV p7 viroporin, therefore making it useful in the characterization of anti-HCV compounds (Griffin et al, 2004;Luscombe et al, 2010).…”
Section: Introductionmentioning
confidence: 98%
“…Similarly to hepaciviruses, p7 plays an essential role in the life cycle of pestiviruses and contributes to their pathogenicity (Gladue et al, 2012;Griffin et al, 2004;Luscombe et al, 2010). It has been argued that the pestivirus p7 constitutes a general model for the HCV p7 viroporin, therefore making it useful in the characterization of anti-HCV compounds (Griffin et al, 2004;Luscombe et al, 2010).…”
Section: Introductionmentioning
confidence: 98%
“…amantadine, rimantadine, and N-((5-(thiophen-2-yl)isoxazol-3-yl)methyl)-adamantan-1-amine (M2WJ352) (Wang et al, 2013b). (B) Acylguanidines: HMA (Gazina and Petrou, 2012), BIT-225 (Khoury et al, 2010;Luscombe et al, 2010), EIPA, and BIT-314.…”
Section: Methodsmentioning
confidence: 99%
“…HMA has also been reported to inhibit M2(WT) (IC 50 5 1.1 mM by TEVC) but not M2(S31N), whereas a related compound N-(5-(1-methyl-1H-pyrazol-4-yl)naphthalene-2-carbonyl)guanidine (BIT-225; Fig. 1B) inhibits currents from the viroporins of hepatitis C and HIV-1 and shows promising activity in early clinical trials (Khoury et al, 2010;Luscombe et al, 2010;Gazina and Petrou, 2012). Although additional acylguanidines, including ethyl-isopropyl amiloride (EIPA) and (6-(1-methylpryazol-4-yl)-2-napthoyl)guanidinium (BIT-314; Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Initial reports suggest that in related BVDV p7 functions as an ion channelforming protein (13). BVDV is sensitive to amantadine (13) and BIT225 (21), known inhibitors of HCV p7 ion channel function. Thus, it is hypothesized that CSFV p7, like HCV p7 and influenza virus M2 proteins, may function as a viroporin involved in pore formation and transport of ions across cell membranes (1,11).…”
mentioning
confidence: 99%